Minot Wealth Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$4.4M Buy
48,251
+37,243
+338% +$3.3M 1.13% 26
2022
Q1
$903K Buy
11,008
+1,263
+13% +$99.6K 0.19% 93
2021
Q4
$747K Buy
9,745
+1,806
+23% +$144K 0.14% 105
2021
Q3
$596K Buy
7,939
+722
+10% +$54.9K 0.13% 113
2021
Q2
$560K Buy
7,217
+386
+6% +$28.7K 0.12% 118
2021
Q1
$502K Sell
6,831
-38,211
-85% -$2.82M 0.13% 115
2020
Q4
$3.52M Buy
45,042
+3,644
+9% +$279K 1.05% 36
2020
Q3
$3.28M Buy
41,398
+10,089
+32% +$790K 1.23% 30
2020
Q2
$2.31M Buy
31,309
+10,320
+49% +$777K 1.15% 36
2020
Q1
$1.54M Buy
20,989
+17,600
+519% +$1.38M 1.1% 32
2019
Q4
$290K Buy
+3,389
New +$278K 0.13% 109

Other funds holding MRK

Minot Wealth Management's MRK Position: Q2 2022 in Review

Minot Wealth Management increased its Merck (MRK) stake by 338% in Q2 2022, buying an estimated $3.3M and bringing the position to 48,251 shares worth $4.4M. The position accounts for 1.13% of the portfolio, ranked #26.

Minot Wealth Management first reported a position in MRK in Q4 2019 and has held it in 11 quarters since. 3,014 funds tracked by Wall St. Rank hold MRK as of Q2 2022.

  • Minot Wealth Management held 48,251 shares of Merck worth $4.4M as of Q2 2022.
  • Minot Wealth Management bought 37,243 Merck shares in Q2 2022, an estimated $3.3M.
  • Merck made up 1.13% of Minot Wealth Management's portfolio in Q2 2022, its #26 holding.
  • Minot Wealth Management first reported a position in Merck in Q4 2019 and has held it in 11 quarters since.
  • 3,014 funds tracked by Wall St. Rank held Merck as of Q2 2022.

Based on Minot Wealth Management's 13F filing for Q2 2022, filed 12 Jul 2022.